Forcan — Research Summary
Forcan 200 mg is a triazole antifungal pharmaceutical manufactured by Cipla containing fluconazole as the active ingredient. This azole-class antifungal agent provides researchers with a valuable tool for investigating fungal biology, antifungal resistance mechanisms, and drug interaction pathways in controlled laboratory environments. Each tablet contains precisely 200mg of fluconazole, enabling consistent dosing protocols in mycological research studies. The compound’s broad-spectrum antifungal properties make it particularly useful for examining Candida species, Cryptococcus neoformans, and other pathogenic fungi in vitro.
Research teams studying antifungal pharmacology frequently examine fluconazole’s mechanism of action, which involves selective inhibition of fungal cytochrome P450 enzyme 14α-demethylase. This enzyme plays a crucial role in ergosterol biosynthesis, making it an essential target for antifungal research. Scientists at Stroid UK Shop can access genuine Cipla pharmaceuticals for their laboratory investigations, supported by comprehensive documentation and quality assurance protocols.
Laboratory Applications
Investigators utilise Forcan tablets to study various aspects of antifungal pharmacology, including bioavailability studies, resistance development patterns, and combination therapy effects. The compound’s well-documented pharmacokinetic profile makes it suitable for comparative studies with other fluconazole preparations and novel antifungal compounds. Research applications encompass minimum inhibitory concentration determinations, time-kill studies, and synergy testing with other antimicrobial agents.
Mycology laboratories often incorporate fluconazole research into broader studies examining fungal pathogenesis and host-pathogen interactions. The compound’s selective toxicity towards fungal cells while maintaining relatively low mammalian cell toxicity makes it valuable for studying therapeutic windows and safety margins. Researchers investigating drug resistance mechanisms frequently compare fluconazole-sensitive and resistant isolates to understand molecular changes affecting azole susceptibility. These studies complement research conducted with selective androgen receptor modulators and research peptides in pharmaceutical development programmes.
Product Specifications
| Active Ingredient | Fluconazole 200mg |
|---|---|
| Manufacturer | Cipla Limited |
| CAS Number | 86386-73-4 |
| Molecular Formula | C₁₃H₁₂F₂N₆O |
| Molecular Weight | 306.27 g/mol |
| Storage Conditions | Room temperature, dry location |
| Shelf Life | As per manufacturer labeling |
Research Compliance
Forcan 200 mg tablets are supplied exclusively for in-vitro research applications and laboratory analysis. This pharmaceutical preparation is not intended for human consumption, clinical use, or any therapeutic applications. Researchers must ensure appropriate institutional approval and safety protocols when handling pharmaceutical compounds in laboratory settings. All studies should be conducted under proper supervision with adequate safety measures and waste disposal procedures in accordance with institutional guidelines.
